Checkpoint Therapeutics Receives Approval for PD-L1 TherapyDecember 16, 2024The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Concerned About Skin Cancer? Here’s What You Should be Asking Your DermatologistDecember 5, 2023Your skin is your body’s first line of defense. Taking care of it is essential, especially when it comes to…
Nov. 05, 2024Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure
Sep. 24, 2024Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer